Assessing the impact of a safe and equitable biosimilar policy in the United States: hearing before the Subcommittee on Health of the Committee on Ene by United S. Congress, United States House of Representatives, Committee on Energy and Commerc (house)

Assessing the impact of a safe and equitable biosimilar policy in the United States: hearing before the Subcommittee on Health of the Committee on Ene

United S. Congress, United States House of Representatives, Committee on Energy and Commerc (house)

192 pages • missing pub info (editions)

nonfiction politics
Powered by AI (Beta)
Loading...

Description

Assessing the impact of a safe and equitable biosimilar policy in the United States: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.

Community Reviews

Loading...

Content Warnings

Loading...